Partner David Simon was quoted in an Agenda article, “SEC, DOJ to Trim FCPA Enforcement in 2017.” The article discussed how new leadership at the SEC and DOJ in 2017 may impact enforcement at both agencies, particularly as it relates to prioritization of anti-bribery and corruption compliance. In reference to Jeff Sessions as the new attorney general, Simon said Sessions is viewed as a “prosecute or don’t prosecute kind of guy.” Under Sessions’ leadership, the DOJ could take a more black-and-white approach to the FCPA, issuing fewer deferred and non-prosecution agreements over gray-area cases, he said.
The article also focused on the DOJ’s FCPA pilot program and whether it will continue under the Trump administration. Simon said that, “My optimistic side says if the new administration is trying to make this more of a pro-business paradigm, they’ll actually take it further and build more certainty in.”
The article also focused on the DOJ’s FCPA pilot program and whether it will continue under the Trump administration. Simon said that, “My optimistic side says if the new administration is trying to make this more of a pro-business paradigm, they’ll actually take it further and build more certainty in.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."